Cargando…
Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis
Effect of raloxifene (RLF) on the improvement of inhibited osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) resulted from tumor necrosis factor-α (TNF-α) induction, thus alleviating the progression of osteoporosis (OP), was investigated. An in vivo OP rat model was constructe...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296296/ https://www.ncbi.nlm.nih.gov/pubmed/32550885 http://dx.doi.org/10.3892/etm.2020.8689 |
_version_ | 1783546820333404160 |
---|---|
author | Yang, Fenghe Jia, Yusong Sun, Qi Zheng, Chenying Liu, Chuyin Wang, Wei Du, Li Kang, Shengqian Niu, Xufeng Li, Jinyu |
author_facet | Yang, Fenghe Jia, Yusong Sun, Qi Zheng, Chenying Liu, Chuyin Wang, Wei Du, Li Kang, Shengqian Niu, Xufeng Li, Jinyu |
author_sort | Yang, Fenghe |
collection | PubMed |
description | Effect of raloxifene (RLF) on the improvement of inhibited osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) resulted from tumor necrosis factor-α (TNF-α) induction, thus alleviating the progression of osteoporosis (OP), was investigated. An in vivo OP rat model was constructed by performing the procedures of ovariectomy (OVX). Rats were randomly divided into sham group, OVX group and RLF+OVX group. BMSCs were extracted from healthy rats, and randomly divided into control group, TNF-α group, RLF group and TNF-α+RLF group. Viability and cellular calcification ability in each group were detected. The relative levels of osteocalcin (OCN), Runx2 and NF-κB in cells with different treatments were determined. The body weight of rats in the OVX group and RLF+OVX group gradually increased compared with that in the sham group on the 8th week. No significant difference in body weight was observed between the rats of the OVX group and RLF+OVX group. Bone metabolism index (BMD) in the rats of the RLF+OVX group was higher than that of the OVX group, and lower compared with that of the sham group. Compared with the sham group, the elastic/max radial degree and elastic/max load of femora were reduced in the OVX group and RLF+OVX group, especially in the OVX group. The relative levels of OCN and Runx2, as well as the ALP activity and calcification ability, were decreased in the OVX group compared with the sham group, and the effect was partially reversed by the RLF treatment. After osteogenic differentiation of BMSCs, the viability and calcification ability were markedly reduced in TNF-α group, which was reversed by RLF treatment. Moreover, TNF-α induction downregulated the relative levels of OCN and Runx2, and RLF treatment could enhance their levels. The upregulated NF-κB protein level, induced by TNF-α, was reduced after RLF treatment. TNF-α induction inhibits osteogenic differentiation of BMSCs, which could be remarkably alleviated by RLF. It is suggested that RLF contributes to the alleviation of OP progression. |
format | Online Article Text |
id | pubmed-7296296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-72962962020-06-17 Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis Yang, Fenghe Jia, Yusong Sun, Qi Zheng, Chenying Liu, Chuyin Wang, Wei Du, Li Kang, Shengqian Niu, Xufeng Li, Jinyu Exp Ther Med Articles Effect of raloxifene (RLF) on the improvement of inhibited osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) resulted from tumor necrosis factor-α (TNF-α) induction, thus alleviating the progression of osteoporosis (OP), was investigated. An in vivo OP rat model was constructed by performing the procedures of ovariectomy (OVX). Rats were randomly divided into sham group, OVX group and RLF+OVX group. BMSCs were extracted from healthy rats, and randomly divided into control group, TNF-α group, RLF group and TNF-α+RLF group. Viability and cellular calcification ability in each group were detected. The relative levels of osteocalcin (OCN), Runx2 and NF-κB in cells with different treatments were determined. The body weight of rats in the OVX group and RLF+OVX group gradually increased compared with that in the sham group on the 8th week. No significant difference in body weight was observed between the rats of the OVX group and RLF+OVX group. Bone metabolism index (BMD) in the rats of the RLF+OVX group was higher than that of the OVX group, and lower compared with that of the sham group. Compared with the sham group, the elastic/max radial degree and elastic/max load of femora were reduced in the OVX group and RLF+OVX group, especially in the OVX group. The relative levels of OCN and Runx2, as well as the ALP activity and calcification ability, were decreased in the OVX group compared with the sham group, and the effect was partially reversed by the RLF treatment. After osteogenic differentiation of BMSCs, the viability and calcification ability were markedly reduced in TNF-α group, which was reversed by RLF treatment. Moreover, TNF-α induction downregulated the relative levels of OCN and Runx2, and RLF treatment could enhance their levels. The upregulated NF-κB protein level, induced by TNF-α, was reduced after RLF treatment. TNF-α induction inhibits osteogenic differentiation of BMSCs, which could be remarkably alleviated by RLF. It is suggested that RLF contributes to the alleviation of OP progression. D.A. Spandidos 2020-07 2020-04-27 /pmc/articles/PMC7296296/ /pubmed/32550885 http://dx.doi.org/10.3892/etm.2020.8689 Text en Copyright: © Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Yang, Fenghe Jia, Yusong Sun, Qi Zheng, Chenying Liu, Chuyin Wang, Wei Du, Li Kang, Shengqian Niu, Xufeng Li, Jinyu Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
title | Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
title_full | Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
title_fullStr | Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
title_full_unstemmed | Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
title_short | Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
title_sort | raloxifene improves tnf-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296296/ https://www.ncbi.nlm.nih.gov/pubmed/32550885 http://dx.doi.org/10.3892/etm.2020.8689 |
work_keys_str_mv | AT yangfenghe raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT jiayusong raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT sunqi raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT zhengchenying raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT liuchuyin raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT wangwei raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT duli raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT kangshengqian raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT niuxufeng raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis AT lijinyu raloxifeneimprovestnfainducedosteogenicdifferentiationinhibitionofbonemarrowmesenchymalstemcellsandalleviatesosteoporosis |